The incidence of scintigraphically viable and nonviable tissue by rubidium-82 and fluorine-18-fluorodeoxyglucose position emission tomographic imaging in patients with prior infarction and left ventricular dysfunction

Journal of Nuclear Cardiology

Volumn 3, Issue 2, 1996, Pages 96-104

  Go, Raymundo T ^a   MacIntyre, William J ^b   Cook, Sebastian A ^b   Neumann, Donald R ^b   Brunken, Richard C ^b   Saha, Gopal B ^b   Underwood, Donald A ^b   Marwick, Thomas H ^b   Chen, Eric Q ^b   King, Janet L ^b   Khandekar, Shashi ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RUBIDIUM 82;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART MUSCLE PERFUSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIODIAGNOSIS; SCINTIGRAPHY;

EID: 15844400086     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(96)90001-X     Document Type: Article

References (25)

1. Rahimtoola SH. A perspective on the three large multicentered randomized clinical trials of coronary artery bypass surgery for chronic stable angina. Circulation 1985;72(suppl):V123-35.
2. Rahimtoola SH. The hibernating myocardium. Am Heart J 1989; 117:211-21.
3. Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. N Engl J Med 1986;314:884-8.
4. Go RT, Marwick TH, MacIntyre WJ, et al. A prospective comparison of rubidium-82 PET and thallium-201 SPECT myocardial perfusion imaging utilizing a single dipyridamole stress in the diagnosis of coronary artery disease. J Nucl Med 1990;30:1899-905.
5. Go RT, MacIntyre WJ, Saha GB, et al. Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability. Radiology 1995;194:151-5.
6. Hicks RJ, Herman WH, Kalff V, et al. Quantitative evaluation of regional substrate metabolism in the human heart by positron emission tomography. J Am Coll Cardiol 1991;18:101-11.
7. Choi Y, Brunken RC, Hawkins RA, et al. Factors affecting myocardial 2-[F-18]fluoro-2-deoxy-D-glucose uptake in positron emission tomography studies of normal humans. Eur J Nucl Med 1993;20:308-18.
8. Gropler RJ. Methodology governing the assessment of myocardial glucose metabolism by positron emission tomography and fluorodeoxyglucose. J NUCL CARDIOL 1994;1:S4-14.
9. Di Carli MF, Davidson M, Little R, et al. Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. Am J Cardiol 1994;73:527-33.
10. Gibson RS, Watson DD, Craddock GB, et al. Prediction of cardiac events after uncomplicated myocardial infarction: a prospective study comparing predischarge exercise thallium-201 scintigraphy and coronary angiography. Circulation 1983;68:321-36.
11. Leppo JA, O'Brien J, Rothendler JA, Getchell JD, Lee VW. Dipyridamole-thallium-201 scintigraphy in the prediction of future cardiac events after acute myocardial infarction. N Engl J Med 1984;310:1014-8.
12. Vanoverschelde JLJ, Wijns W, Depré C, et al. Mechanisms of chronic regional postischemic dysfunction in humans. Circulation 1993;87:1513-23.
13. Carrel T, Jenni R, Haubold-Reuter S, von Schulthess G, Pasic M, Turina M. Improvement of severely reduced left ventricular function after surgical revascularization in patients with preoperative myocardial infarction. Eur J Cardiothorac Surg 1992;6:479-84.
14. Gropler RJ, Geltman EM, Sampathkumaran K, et al. Functional recovery after coronary revascularization for chronic coronary artery disease is dependent on maintenance of oxidative metabolism. J Am Coll Cardiol 1992;20:569-77.
15. Eitzman D, Al-Aovar Z, Kanter HL, et al. Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. J Am Coll Cardiol 1992;20:559-65.
16. Knuuti MJ, Nuutila P, Ruotsalainen U, et al. The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET. J Nucl Med 1993;34:2068-75.
17. 18F-fluorodeoxyglucose. Circulation 1991;83:26-37.
18. Dilsizian V, Freedman N, Bacharach SL, et al. Regional thallium uptake in irreversible defects: magnitude of change in thallium activity after reinjection distinguishes viable from nonviable myocardium. Circulation 1992;85:627-34.
19. Tamaki N, Kawamoto M, Tadamura E, et al. Prediction of reversible ischemia after revascularization: perfusion and metabolic studies with positron emission tomography. Circulation 1995;91:1697-705.
20. Takahashi N, Tamaki N, Kawamoto M, et al. Glucose metabolism in relation to perfusion in patients with ischemic heart disease. Eur J Nucl Med 1994;21:292-6.
21. Duvernoy C, Rothley J, Sitomer J, et al. Relationship of blood flow and functional outcome after coronary revascularization: the role of positron emission tomography [Abstract]. J Nucl Med 1993;34:155.
22. Parodi O, De Maria R, Oltrona L, et al. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation. Circulation 1993;88:509-22.
23. Mori T, Minamiji K, Kurogane H, Ogawa K, Yoshida Y. Restinjected thallium-201 imaging for assessing viability of severe asynergic regions. J Nucl Med 1991;32:1718-24.
24. 201Tl imaging in detection of myocardial viability and prediction of improvement in left ventricular function after coronary bypass surgery in patients with severely depressed left ventricular function. Circulation 1993;87: 1630-41.
25. Gould KL, Yoshida K, Hess MJ, Haynie M, Mullani N, Smalling RW. Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue rubidium-82 for assessing infarct size in man by PET. J Nucl Med 1991;32:1-9.